Literature DB >> 15947325

Eotaxin-3 and interleukin-5 pleural fluid levels are associated with pleural fluid eosinophilia in post-coronary artery bypass grafting pleural effusions.

Ioannis Kalomenidis1, Georgios T Stathopoulos, Randal Barnette, Yubiao Guo, R Stokes Peebles, Timothy S Blackwell, Richard W Light.   

Abstract

OBJECTIVES: The primary aim of this study was to examine the association between pleural fluid (PF) eosinophilia, and the PF and serum levels of interleukin (IL)-5, eotaxin-2, eotaxin-3, and vascular cell adhesion molecule (VCAM)-1 in patients with post-coronary artery bypass grafting (CABG) pleural effusions.
DESIGN: A prospective observational study.
SETTING: A tertiary teaching hospital. PATIENTS AND METHODS: Thirty-eight patients with post-CABG pleural effusions were recruited into the study. An effusion that contained at least 10% eosinophils was called "eosinophilic." The PF and serum levels of the cytokines and VCAM-1 were measured using an enzyme-linked immunosorbent assay.
RESULTS: (1) The number of PF eosinophils significantly correlated with the number of blood eosinophils. (2) PF IL-5 levels were significantly higher than the corresponding serum levels, and there was a significant correlation between the PF and serum IL-5 levels. PF IL-5 levels significantly correlated with the PF eosinophil count, and serum IL-5 levels significantly correlated with the number of blood eosinophils. (3) PF eotaxin-3 levels were significantly higher than serum levels, and PF eotaxin-3 levels significantly correlated with the PF eosinophil count. (4) PF VCAM-1 levels were significantly lower than the corresponding serum levels, and PF VCAM-1 levels were significantly higher in eosinophilic pleural effusions (EPEs) than in non-EPEs.
CONCLUSION: In patients with post-CABG pleural effusions, IL-5 and eotaxin-3 are produced preferentially in the pleural cavity, and they are strongly associated with PF eosinophilia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15947325     DOI: 10.1378/chest.127.6.2094

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  7 in total

Review 1.  At the bedside: the emergence of group 2 innate lymphoid cells in human disease.

Authors:  R Stokes Peebles
Journal:  J Leukoc Biol       Date:  2014-12-16       Impact factor: 4.962

2.  Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses.

Authors:  C Blanchard; M K Mingler; M McBride; P E Putnam; M H Collins; G Chang; K Stringer; J P Abonia; J D Molkentin; M E Rothenberg
Journal:  Mucosal Immunol       Date:  2008-05-07       Impact factor: 7.313

3.  Activation of the stress axis and neurochemical alterations in specific brain areas by concentrated ambient particle exposure with concomitant allergic airway disease.

Authors:  Madhu P Sirivelu; Sheba M J MohanKumar; James G Wagner; Jack R Harkema; Puliyur S MohanKumar
Journal:  Environ Health Perspect       Date:  2006-06       Impact factor: 9.031

Review 4.  Chemokines and immunity.

Authors:  Diana Carolina Torres Palomino; Luciana Cavalheiro Marti
Journal:  Einstein (Sao Paulo)       Date:  2015 Jul-Sep

Review 5.  Severe Eosinophilic Asthma.

Authors:  Agamemnon Bakakos; Stelios Loukides; Petros Bakakos
Journal:  J Clin Med       Date:  2019-09-02       Impact factor: 4.241

Review 6.  Serous fluids and hematolymphoid disorders.

Authors:  Ali Gabali
Journal:  Cytojournal       Date:  2022-03-19       Impact factor: 2.345

Review 7.  Bioinformatic analysis of eosinophil activity and its implications for model and target species.

Authors:  C J Jenvey; D Alenizi; F Almasi; C Cairns; A Holmes; S Sloan; M J Stear
Journal:  Parasitology       Date:  2019-12-16       Impact factor: 3.234

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.